Osteoporosis and β-thalassemia major: Role of the IGF-I/IGFBP-III axis

Journal of Endocrinological Investigation

Volumn 25, Issue 4, 2002, Pages 338-344

  Lasco, A ^a   Morabito, N ^a   Gaudio, A ^a   Crisafulli, A ^a   Meo, A ^a   Denuzzo, G ^a   Frisina, N ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Bone turnover; IGF I; IGFBP III; Osteoporosis; Thalassemia

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; BIOCHEMICAL MARKER; CALCIUM; COLECALCIFEROL; CREATININE; DEFEROXAMINE MESYLATE; DEOXYPYRIDINOLINE; ESTRADIOL; ESTROGEN; FERRITIN; HEMOGLOBIN; MEDROXYPROGESTERONE ACETATE; METHYLTESTOSTERONE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; PYRIDINOLINE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROXINE;

ADULT; ANTHROPOMETRY; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE REMODELING; BONE TURNOVER; CHELATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE URINE LEVEL; DISEASE MARKER; DISEASE PREDISPOSITION; DOSE CALCULATION; DRUG MONITORING; FEMALE; FEMUR NECK; FERRITIN BLOOD LEVEL; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL SIGNIFICANCE; THALASSEMIA MAJOR; VITAMIN SUPPLEMENTATION;

ADULT; BETA-THALASSEMIA; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CROSS-SECTIONAL STUDIES; DEFEROXAMINE; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR NECK; HORMONE REPLACEMENT THERAPY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; IRON CHELATING AGENTS; LUMBAR VERTEBRAE; MALE; MEDROXYPROGESTERONE 17-ACETATE; METHYLTESTOSTERONE; OSTEOPOROSIS; REFERENCE VALUES;

EID: 0036229280     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344015     Document Type: Article

References (39)

1. Anemia in children with splenomegaly and peculiar changes in bones
2. High prevalence of low bone mass in thalassaemia major
3. Abnormal bone metabolism in thalassaemia
4. Relationship between transfusion regimen and suppression of erythropiesis in beta-thalassemia major
5. Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major
6. Iron-endocrine pattern in patients with β-thalassaemia
7. Calcium phosphate metabolism in thalassemia
8. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: New therapeutic approaches
9. Endocrine abnormalities in thalassaemia
10. Effects of hormonal replacement therapy on bone metabolism in young adults with β-thalassemia major
11. Insulin-like growth factors
12. IGF binding proteins: Regulation of cellular actions
13. The laboratory diagnosis of haemoglobinopathies
14. Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia
15. Bone growth factors
16. The insulin-like growth factor system and the coupling of formation to resorption
17. Bone resorption is increased in young adults with thalassaemia major
18. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia
19. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major
20. Evaluation of hypothalamic-pituitary function in patients with thalassemia major
21. Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major
22. Normal growth hormone response to GH-releasing hormone in children with thalassemia major before puberty: A possible age related effect
23. Neurosecretory dysfunction of growth hormone secretion in thalassemia major
24. Circadian growth hormone secretion in short multitransfused prepubertal children with thalassemia major
25. Evaluation of growth hormone in thalassemic boys with failed puberty: Spontaneous versus provocative test
26. No evidence for a defect in growth hormone binding to liver membranes in thalassemia major
27. Novel application of IGF-I and IGFBP-III generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassaemia
28. GH, IGF-I and binding proteins in altered nutritional states
29. Insulin-like growth factors and their binding proteins: Biological actions
30. Insulin-like growth factor I supports differentiation of cultered osteoblast like cells
31. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication
32. Growth hormone-dependent stimulation of osteoblast-like cells in serum free cultures via local synthesis of insulin-like growth factor I
33. Isolation of growth factors from adult bovine bone
34. Cortisol enhances the anabolic effects of insulin-like growth factor I on collagen synthesis and procollagen messenger ribonucleic acid levels in cultered 21-day fetal rat calvariae
35. Anabolic hormones in bone: Basic research and therapeutic potential
36. Characterization and function of the receptor for IGF-I in human preosteoclastic cells
37. Insulin-like growth factor binding protein-3: Biochemistry and physiology
38. Bone mineral density in prepubertal children with beta-thalassemia: Correlation with growth and hormonal data
39. Bone disease in beta-thalassaemia major